Sitagliptin phosphate

Sitagliptin phosphate Structure
CAS No.
654671-78-0
Chemical Name:
Sitagliptin phosphate
Synonyms
Sitagliptin Phosphat;3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]-pyrazin-7(8H)-yl)-4-(2,4,5-t;(3R)-3-aMino-1-[3-(trifluoroMethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;SIT-11;CS-1358;sitagpliptin;Sitagliptin, MK 0431;Sitagliptin phosphate;Sitagliptin Phosphatec;Sitagliptin phosphate salt
CBNumber:
CB71179744
Molecular Formula:
C16H15F6N5O.H3PO4
Molecular Weight:
505.31
MOL File:
654671-78-0.mol
Modify Date:
2024/4/12 23:00:59

Sitagliptin phosphate Properties

Melting point 202-204°C
storage temp. -20°C Freezer
solubility Methanol (Slightly, Heated), Water (Sparingly, Sonicated)
form Solid
color White to Off-White
InChI InChI=1S/C16H15F6N5O.H3O4P/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22;1-5(2,3)4/h4,6,9H,1-3,5,7,23H2;(H3,1,2,3,4)
InChIKey IQFYVLUXQXSJJN-UHFFFAOYSA-N
SMILES C(C1=CC(F)=C(F)C=C1F)C(N)CC(=O)N1CCN2C(C(F)(F)F)=NN=C2C1.P(O)(O)(O)=O

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
NFPA 704
0
2 0

Sitagliptin phosphate Chemical Properties,Uses,Production

Description

Sitagliptin is the first novel dipeptidyl peptidase IV inhibitor from Merck for the treatment of type 2 diabetes without weight gain and the incidence of hypoglycemia was similar to placebo. Sitagliptin acts by enhancing the body’s incretin system, which helps to regulate glucose by affecting β and α cells in the pancreas.

Chemical Properties

White Solid

Uses

A trizolopyrazine dipeptidyl peptidase IV inhibitor. It has recently been approved for the therapy of type II diabetes.

General Description

Sitagliptin phosphate is the 1:1 phosphoric acid salt ofsitagliptin free base (i.e., (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)-2-butanamine), and is marketed(Junuvia, 2006) in 25-, 50-, and 100-mg tablets. Acombination product with metformin (Janumet, 2007) intwo strengths (50 mg/500 mg and 50 mg/1,000 mgsitagliptin/metformin) is also available, and sitagliptin mayalso be prescribed with a thiazolidinedione, or possibly a sulfonylurea.The phosphate salt provides very high water solubility.The bioavailability of orally administered sitagliptinis~87%. The drug exhibits relatively low plasma protein binding (~38%), a relatively large volume of distribution(198 L), and a terminal elimination half-life of 12 hours.About 79% of a 100-mg oral dose is excreted unchanged inurine, the balance as trace-level metabolites (CYP3A4, lessercontribution by CYP2C8) in urine or feces: 87% of administeredradioactivity is excreted in urine, and 13% in feces.Active tubular excretion is reported to play a key role in renalclearance of unchanged drug, and may be mediated at least inpart via the organic anion transporter hOAT-3.

Sitagliptin phosphate Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 358)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
SURYA LIFE SCIENCES LIMITED +91-2646226290 +91-9428511112 Gujarat, India 62 58 Inquiry
ANWITA APIS +919000311012 Hyderabad, India 198 58 Inquiry
Dr. Reddy's Laboratories Ltd +91-4049002900 +91-4049002900 Hyderabad, India 165 58 Inquiry
Bulat Pharmaceutical Pvt Ltd +91-8448085659 +91-8448085660 Haryana, India 123 58 Inquiry
SKVen Technologies Pvt.Ltd. +91-7032295152 +91-7032295152 Hyderabad, India 81 58 Inquiry
AARTIA KEM SCIENCE +91-8291072530 +91-8291072530 Maharashtra, India 70 58 Inquiry
Sekhment pharmaventures +91-9030088669 +91-9030088669 Mumbai, India 105 58 Inquiry
Aurobindo Pharma Limited +914066725000 Telangana, India 112 58 Inquiry
Aalidhra Pharmachem Pvt Ltd +91-9879180894 +91-9879180894 Gujarat, India 38 58 Inquiry
Honour Lab Limited +919845977466 Telangana, India 164 58 Inquiry

Sitagliptin phosphate Spectrum

7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-α]pyrazine-phosphate Sitagliptin phosphate 4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate sitagpliptin Sitagliptin phosphate 4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate Sitagliptin phosphate/Sitagliptin phosphate Monohydrate/Sitagliptin Sitagliptin phosphate (Cas:654671-78-0... (3R)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-1-butanone phosphate 1-Butanone, 3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-, (3R)-, phosphate (1:1) Sitagliptin, MK 0431 CS-1358 Sitagliptin phosphate salt 99% Sitagliptin Phosphate? Sitagliptin phosphate USP/EP/BP Sitagliptin phosphate (API) Sitagliptin PhosphateQ: What is Sitagliptin Phosphate Q: What is the CAS Number of Sitagliptin Phosphate Q: What is the storage condition of Sitagliptin Phosphate Sitagliptin Phosphatec 3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]-pyrazin-7(8H)-yl)-4-(2,4,5-t (3R)-3-aMino-1-[3-(trifluoroMethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one Sitagliptin Phosphat SIT-11 Sitagliptin Impurity 19 Phosphate Sitagliptin Phosphate (Monohydrate and Anhydrous) Sitagliptin Impurity 14 Phosphate Siagliptin phosphate monohydrate 654671-78-0 C16H15F6N5OH3O4P C16H15F6N5OH3PO4 API Intermediates & Fine Chemicals Pharmaceuticals Pharmaceutical intermdiate All Inhibitors Inhibitors 654671-78-0